SOLY · Soliton Inc

-

Please sign in to comment on SOLY

1 Comment

Admin

4 years ago

Soliton, Inc is currently in a long term uptrend where the price is trading 60.7% above its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.

Soliton, Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.

Its net income has dropped by 38.7% to $-5M since the same quarter in the previous year.

Finally, its free cash flow fell by 29.5% to $-3M since the same quarter in the previous year.

Based on the above factors, Soliton, Inc gets an overall score of 2/5.

ISIN	US8342511008
Sector	Healthcare
Exchange	NASDAQ
CurrencyCode	USD
Industry	Medical Devices

Market Cap	488M
PE Ratio	None
Beta	0.18
Dividend Yield	0.0%
Target Price	22.6

ABOUT

Soliton Inc

Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.

SOLY · Soliton Inc

-

Soliton Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Soliton Inc using a moving average strategy